Oslo, Norway, 22 March 2018
On 16 March 2018, Vistin Pharma ASA ("Vistin Pharma" or the "Company") announced that it had hired Torbjørn Kjus and Kenneth Tveter to establish a new business area within energy trading.
Please see attached a short introduction to the preliminary plans regarding the new business area. Since the Company is entering a new business area, the attached presentation includes updated risk factors related to the Company.
For further information, please contact:
Ole Enger
Chairman
+47 91 13 82 23
Gunnar Manum
CFO
+47 95 17 91 90
[email protected]